Keynote Speakers
Alan Wright Chief Medical Officer, Roche Diagnostics Corporation |
James Hickman Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos |
Xianqiang Mi Professor, Shanghai Advanced Research Institute Chinese Academy of Sciences |
Chamindie Punyadeera Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology |
Steve Soper Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas |
David Wong Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles |
|
Juan Santiago Charles Lee Powell Foundation Professor, Stanford University |
Michael Heller Professor, Dept Bioengineering, University of California-San Diego |
Charles Henry Professor and Chair, Colorado State University |
Abraham Lee Chancellor’s Professor, Biomedical Engineering & Director, Center for Advanced Design & Manufacturing of Integrated Microfluidics, University of California-Irvine |
Gene Dantsker Director, Business Development and Licensing, Qualcomm LIFE, Inc. |
Jason Heikenfeld Professor and VP Operations, UC Office of Innovation, University of Cincinnati |
John T McDevitt Professor, Division of Biomaterials, New York University College of Dentistry Bioengineering Institute |
Weian Zhao Associate Professor, Department of Biomedical Engineering, University of California-Irvine |
Martyn Boutelle Professor of Biomedical Sensors Engineering, Imperial College London |
Kamlesh Patel R&D Advanced System Engineering and Deployment Manager, Sandia National Laboratories |
Aaron Wheeler Canada Research Chair of Bioanalytical Chemistry, University of Toronto |
Tingrui Pan Professor, Department of Biomedical Engineering, University of California-Davis |
Bernhard Weigl Director, Center for In-Vitro Diagnostics, Intellectual Ventures/Global Good-Bill Gates Venture Fund |
James Heath Elizabeth W. Gilloon Professor of Chemistry, California Institute of Technology (CalTech) |
OverviewBringing together the key opinion leaders from both academia and industry, this annual conference now in its 4th year will discuss the expanding Point-of-Care Diagnostics and Global Health
fields and provide the most up-to-date presentations from leaders in
these fields and offer networking and engagement opportunities with
delegates from around the world.
This conference will provide an
overview of the point-of-care (POC) testing landscape, from novel
technologies to regulatory approval. Experts in these fields will share
their views on point-of-care in the clinical setting. The aim of this
meeting is to bring together life science researchers that work at the
interface between biology and chemistry and technology development to
discuss problems, highlight solutions and facilitating collaborations.
Also, we frame the role of POC testing in the expanding Global Health
field and highlight opportunities existing in many parts of the world.
This
conference covers POC Detection, POC Diagnostics and POC-based
Treatment Options as part of the Comprehensive Coverage of this
Expanding Field. The POC testing field is expanding focused not only on
infectious disease diagnostics (which represents approximately 80% of
the marketplace) but also with cancer and cardiovascular disease focus.
We address each of these segments in this conference.
Registered conference delegates have access to the co-located parallel conference tracks:
1. Lab-on-a-Chip and Microfluidics: Emerging Themes, Technologies and Applications 2. Lab-on-a-Chip and Microfluidics: Techologies and Commercialization 3. Point-of-Care Diagnostics & Global Health World Congress 2016 4.
Next-Generation Sequencing (NGS), Single-Cell Analysis (SCA), Single
Molecule Analysis (SMA) & Mass Spectrometry: Research to Diagnostics
2016
The Exhibit Hall is Co-Located with the Conference Tracks and is open September 27 and 28, 2016.
Session Sponsors
Agenda Topics- Emerging Technologies and Emerging Companies Showcase
- POC Diagnostics for Global Health: A Worldwide Perspective
- POC Diagnostics in Cancer and Oncology Testing
- POC Diagnostics in Cardiovascular Disease Testing
- Point-of-Care Diagnostics in Infectious Disease Testing
- The Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
- Centrifugal Microfluidics
- Low-Cost POC Devices for Deployment Worldwide
- Paper-based Microfluidics
- POC Diagnostics in Resource-Limited Settings
- Using Microfluidics to Capture and Interrogate Various Analyte Classes for POC Testing
- Worldwide Regulatory Trends and Hurdles in the Deployment of POC Testing for Global Health
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateHaim Bau, Professor, University Of Pennsylvania Holger Becker, Chief Scientific Officer, Microfluidic ChipShop GmbH Manish Biyani, Associate Professor, Japan Advanced Institute of Science and Technology James Boiani, Partner, Epstein Becker & Green, P.C. John Brennan, Professor and Director, Biointerfaces Institute, McMaster University Jane Brock, Chief of Breast Pathology, Brigham and Women’s Hospital, Harvard Medical School Josephine Cunningham, Senior Scientist, Paratus Diagnostics Mike Harvey, Chief Science Officer, GVS Life Sciences Lee Hubble, Senior Research Scientist, Commonwealth Scientific and Industrial Research Organisation (CSIRO) Hyun-Duck Kim, Professor, Seoul National University Marya Lieberman, Professor, University of Notre Dame Changchun Liu, Research Associate Professor, University of Pennsylvania Brendan O' Farrell, President, DCN Diagnostics Sergey Shevkoplyas, Associate Professor, University Of Houston Barbara Smith, Assistant Professor, School of Biological and Health Systems Engineering, Arizona State University Hariharan Subramanian, Research Assistant Professor; Chief Technology Officer, NanoCytomics, Northwestern University Felix von Stetten, Associate Director, Hahn-Schickard
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|